Abstract

The mechanisms underlying the natural control of hepatitis B virus (HBV) infection have long been an intriguing question. Given the wide physiological range of liver stiffness and the growing attention to the role of mechanical microenvironment in homeostasis and diseases, we investigated how physical matrix cues impact HBV replication. High matrix stiffness significantly inhibited HBV replication and activated YAP in primary hepatocyte culture system, a key molecule in mechanosignaling. YAP activation notably suppressed HBV transcription and antigen expression. Several YAP-induced genes exhibited strong anti-HBV effects. Single-cell analysis of liver tissue from male individuals with active HBV replication revealed a strong significant negative correlation between YAP signature activation and HBV transcript levels. Intraperitoneal administration of YAP small molecule agonist potently controls HBV in male mouse models. These findings unveil a mechanism that involves the mechanical environment of hepatocytes and YAP to clear hepatotropic viral infection in the liver, providing new perspectives for HBV cure studies and antiviral development.

The mechanisms of the natural control of hepatitis B virus infection remain obscured. Here, the authors reveal that matrix stiffness influences HBV replication via YAP-mediated mechanosignaling, uncovering a novel non-cytolytic mechanism for clearing viral infections in the liver.

Details

Title
Liver mechanosignaling as a natural anti-hepatitis B virus mechanism
Author
Ye, Jianyu 1   VIAFID ORCID Logo  ; Li, Fahong 2 ; Hua, Ting 1 ; Ma, Kewei 3 ; Wang, Jinyu 2 ; Zhao, Zixin 3 ; Yang, Zhongning 1 ; Luo, Chen 1 ; Jia, Ruohan 1 ; Li, Yaming 1 ; Hao, Menghan 1 ; Wu, Jian 3   VIAFID ORCID Logo  ; Lu, Mengji 4 ; Yuan, Zhenghong 1   VIAFID ORCID Logo  ; Zhang, Jiming 2   VIAFID ORCID Logo  ; Chen, Jieliang 1   VIAFID ORCID Logo 

 Shanghai Medical College Fudan University, Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Huashan Hospital, Shanghai, China (GRID:grid.11841.3d) (ISNI:0000 0004 0619 8943); Fudan University, Shanghai Frontiers Science Center of Pathogenic Microorganisms and Infection, Shanghai Institute of Infectious Diseases and Biosecurity, Research Unit of Cure of Chronic Hepatitis B Virus Infection (CAMS), Shanghai, China (GRID:grid.8547.e) (ISNI:0000 0001 0125 2443) 
 Shanghai Medical College Fudan University, Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Huashan Hospital, Shanghai, China (GRID:grid.11841.3d) (ISNI:0000 0004 0619 8943); Fudan University, Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Center for Infectious Diseases, Huashan Hospital, Shanghai, China (GRID:grid.8547.e) (ISNI:0000 0001 0125 2443) 
 Shanghai Medical College Fudan University, Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Huashan Hospital, Shanghai, China (GRID:grid.11841.3d) (ISNI:0000 0004 0619 8943) 
 University of Duisburg-Essen, Institute for Virology, University Hospital Essen, Essen, Germany (GRID:grid.5718.b) (ISNI:0000 0001 2187 5445) 
Pages
8375
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3110560813
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.